FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Litton W Edwin 		2. Issuer Name and Ticker or Trading Symbol

Cellu Tissue Holdings, Inc. [ CLU ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Gen'l Counsel, Sr. V.P.
(Last)          (First)          (Middle)

1855 LOCKEWAY DRIVE, SUITE 501 		3. Date of Earliest Transaction (MM/DD/YYYY)

1/27/2010
(Street)

ALPHARETTA, GA 30004
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   1/27/2010     M (7)    1017   A $2.55   1017   D    
Common Stock   1/27/2010     M (7)    1017   A $2.55   2034   D    
Common Stock   1/27/2010     M (7)    678   A $5.85   2712   D    
Common Stock   1/27/2010     M (7)    339   A $5.64   3051   D    
Common Stock   1/27/2010     M (7)    4507   A $5.28   7558   D    
Common Stock   1/27/2010     D (7)    7558   D $13   0   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option   $2.55   1/27/2010     J   (1)    4181         (2) 8/15/2016   Common Stock   4181   $0   4181   D    
Employee Stock Option   $2.55   1/27/2010     J   (1)    4181         (3) 12/3/2016   Common Stock   4181   $0   4181   D    
Employee Stock Option   $5.85   1/27/2010     J   (1)    4181         (4) 4/9/2017   Common Stock   4181   $0   4181   D    
Employee Stock Option   $5.64   1/27/2010     J   (1)    4181         (5) 4/7/2018   Common Stock   4181   $0   4181   D    
Employee Stock Option   $5.28   1/27/2010     J   (1)    21242         (6) 4/13/2019   Common Stock   21242   $0   21242   D    
Employee Stock Option   $2.55   1/27/2010     J   (1)       4181      (1) 8/15/2016   Common Stock   4181   $0   0   D    
Employee Stock Option   $2.55   1/27/2010     J   (1)       4181      (1) 12/3/2016   Common Stock   4181   $0   0   D    
Employee Stock Option   $5.85   1/27/2010     J   (1)       4181      (1) 4/8/2017   Common Stock   4181   $0   0   D    
Employee Stock Option   $5.64   1/27/2010     J   (1)       4181      (1) 4/7/2018   Common Stock   4181   $0   0   D    
Employee Stock Option   $5.28   1/27/2010     J   (1)       21242      (1) 4/13/2019   Common Stock   21242   $0   0   D    
Employee Stock Option   $2.55   1/27/2010     M   (7)       1017      (2) 8/15/2016   Common Stock   4181   $0   2118   D    
Employee Stock Option   $2.55   1/27/2010     M   (7)       1017      (3) 12/3/2016   Common Stock   4181   $0   2118   D    
Employee Stock Option   $5.85   1/27/2010     M   (7)       678      (4) 4/9/2017   Common Stock   4181   $0   3503   D    
Employee Stock Option   $5.64   1/27/2010     M   (7)       339      (5) 4/7/2018   Common Stock   4181   $0   3842   D    
Employee Stock Option   $5.28   1/27/2010     M   (7)       4507      (6) 4/13/2019   Common Stock   21242   $0   16735   D    
Put Right   $13   1/27/2010     X   (7)       7558      (7)   (7) Common Stock   7558     (7) 0   D    
Employee Stock Option   $11.45   1/27/2010     A      9706         (8) 1/27/2020   Common Stock   9706   $0   9706   D    

Explanation of Responses:
( 1)  Reporting person held options to purchase shares of Common Stock in Cellu Parent Corporation. Pursuant to the terms of the reorganization transactions consummated in connection with the Issuer's initial public offering, as described in the Issuer's Form S-1 Registration Statement dated January 21, 2010, the Cellu Parent Corporation options were exchanged for options to purchase Issuer Common Stock.
( 2)  Upon the exchange described in footnote 1, the option is vested as to 75% of the shares with vesting for the remaining shares to occur on August 15, 2010.
( 3)  Upon the exchange described in footnote 1, the option is vested as to 75% of the shares with vesting for the remaining shares to occur on December 3, 2010.
( 4)  Upon the exchange described in footnote 1, the option is vested as to 50% of the shares with vesting for the remaining shares to occur one-half each on April 1, 2010 and April 1, 2011.
( 5)  Upon the exchange described in footnote 1, the option is vested as to 25% of the shares with vesting for the remaining shares to occur one-third each on April 7, 2010, April 7, 2011 and April 7, 2012.
( 6)  Upon the exchange and the closing of the Issuer's initial public offering, described in footnote 1, options to purchase 13,883 shares are fully vested with vesting for the remaining shares to occur one-quarter each on April 13, 2010, April 13, 2011, April 13, 2012 and April 13, 2013.
( 7)  Reporting Person exercised his right to put to the Issuer, at the initial public offering price, the number of shares receivable upon partial exercise of the various stock options shown above in Table II. The Issuer's compensation committee approved the terms of the put right.
( 8)  Stock option grant under the Issuer's 2010 Equity Compensation Plan. Vests in four equal installments annually beginning on January 27, 2011.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Litton W Edwin
1855 LOCKEWAY DRIVE
SUITE 501
ALPHARETTA, GA 30004

Gen'l Counsel, Sr. V.P.

Signatures
/s/ W. Edwin Litton 1/28/2010
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Canada Life (NYSE:CLU)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos Canada Life.
Canada Life (NYSE:CLU)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos Canada Life.